Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bright Aura for facial hyperpigmentation
NCT06473974Phase 2Withdrawn
- Sponsor
- Kayura Effect
- Start
- Jan 2025
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Kayura Effect. Primary endpoint: Overall hyperpigmentation score using modified Griffiths 10-point scale at 12 weeks. Planned start Jan 2025; status: withdrawn.
Beyond the preview
Go deeper on NCT06473974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06473974.